Founder effect in a Belgian-Dutch fragile X population

Area of Science:

• Genetics
• Molecular Biology
• Human Disease

Background:

• Fragile X syndrome, a leading genetic cause of intellectual disability, was previously attributed to high mutation rates.
• The FMR1 gene and its common CGG repeat amplification mutation are now well-characterized.
• Previous studies in Australian and US populations suggested a founder effect for the fragile X mutation.

Purpose of the Study:

• To investigate the origin and prevalence of fragile X syndrome mutations in Belgian and Dutch populations.
• To determine if de novo mutations contribute significantly to fragile X syndrome cases.
• To assess the presence of linkage disequilibrium and founder effects in these populations.

Main Methods:

• Molecular DNA studies were conducted on 54 Belgian and Dutch fragile X families.
• Analysis focused on the CGG repeat amplification within the FMR1 gene.
• Linkage disequilibrium was assessed between the fragile X mutation and the DXS548 microsatellite marker in 68 unrelated patients.

Main Results:

• No de novo mutations were detected in the studied fragile X families.
• Significant linkage disequilibrium (P < 0.0001) was observed between the fragile X mutation and the DXS548 marker.
• These findings indicate a founder effect for the fragile X mutation in Belgian and Dutch populations.

Conclusions:

• The high prevalence of fragile X syndrome in Belgian and Dutch populations is likely due to a founder effect, not frequent new mutations.
• A limited number of ancestral mutations appear to be responsible for the majority of fragile X syndrome cases.
• Absence of de novo mutations and presence of linkage disequilibrium support a common ancestral origin for the fragile X mutation.